| Gingival crevicular fluid and plasma acute‐phase cytokine levels in different periodontal diseases S Becerik, VÖ Öztürk, H Atmaca, G Atilla, G Emingil Journal of periodontology 83 (10), 1304-1313, 2012 | 165 | 2012 |
| Handbook of anticancer drugs from marine origin SK Kim Springer, 2014 | 117 | 2014 |
| Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K–AKT pathway A Dirican, H Atmaca, E Bozkurt, C Erten, B Karaca, R Uslu Clinical and Translational Oncology 17, 145-151, 2015 | 86 | 2015 |
| Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-terminal telopeptid levels in health and different periodontal diseases S Becerik, B Afacan, VÖ Öztürk, H Atmaca, G Emingil Disease markers 31 (6), 343-352, 2011 | 71 | 2011 |
| Effects of Thymus serpyllum extract on cell proliferation, apoptosis and epigenetic events in human breast cancer cells E Bozkurt, H Atmaca, A Kisim, S Uzunoglu, R Uslu, B Karaca Nutrition and cancer 64 (8), 1245-1250, 2012 | 68 | 2012 |
| Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells G Oktem, A Bilir, R Uslu, SV Inan, SB Demiray, H Atmaca, S Ayla, ... Oncology letters 7 (6), 2103-2109, 2014 | 63 | 2014 |
| Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells B Karabulut, C Erten, MK Gul, E Cengiz, B Karaca, Y Kucukzeybek, ... Cell Biology International 33 (2), 239-246, 2009 | 58 | 2009 |
| Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (−/− gossypol) S Uzunoglu, B Karaca, H Atmaca, A Kisim, C Sezgin, B Karabulut, R Uslu Toxicology mechanisms and methods 20 (8), 482-486, 2010 | 53 | 2010 |
| Effect of centrifugation time on growth factor and MMP release of an experimental platelet-rich fibrin-type product G Eren, A Gürkan, H Atmaca, A Dönmez, G Atilla Platelets 27 (5), 427-432, 2016 | 52 | 2016 |
| Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells B Karaca, H Atmaca, E Bozkurt, A Kisim, S Uzunoglu, B Karabulut, ... Molecular biology reports 40, 3925-3933, 2013 | 45 | 2013 |
| Gingival crevicular fluid interleukin-36β (-1F8), interleukin-36γ (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease SF Kurşunlu, VÖ Öztürk, B Han, H Atmaca, G Emingil Archives of oral biology 60 (1), 77-83, 2015 | 44 | 2015 |
| A diverse induction of apoptosis by trabectedin in MCF-7 (HER2−/ER+) and MDA-MB-453 (HER2+/ER−) breast cancer cells H Atmaca, E Bozkurt, S Uzunoglu, R Uslu, B Karaca Toxicology letters 221 (2), 128-136, 2013 | 44 | 2013 |
| Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone-and drug … Y Kucukzeybek, MK Gul, E Cengiz, C Erten, B Karaca, G Gorumlu, ... Journal of experimental & clinical cancer research 27, 1-8, 2008 | 44 | 2008 |
| Overcoming drug resistance in hormone-and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination E Cengiz, B Karaca, Y Kucukzeybek, G Gorumlu, MK Gul, C Erten, ... Molecular biology reports 37, 1269-1277, 2010 | 41 | 2010 |
| Effects of Galium aparine extract on the cell viability, cell cycle and cell death in breast cancer cell lines H Atmaca, E Bozkurt, M Cittan, HD Tepe Journal of ethnopharmacology 186, 305-310, 2016 | 39 | 2016 |
| Novel benzimidazole derivatives: Synthesis, in vitro cytotoxicity, apoptosis and cell cycle studies H Atmaca, S İlhan, MB Batır, ÇÇ Pulat, A Güner, H Bektaş Chemico-Biological Interactions 327, 109163, 2020 | 38 | 2020 |
| Biological response of osteoblastic and chondrogenic cells to graphene-containing PCL/bioactive glass bilayered scaffolds for osteochondral tissue engineering applications AM Deliormanlı, H Atmaca Applied biochemistry and biotechnology 186, 972-989, 2018 | 36 | 2018 |
| Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 … A Kisim, H Atmaca, B Cakar, B Karabulut, C Sezgin, S Uzunoglu, R Uslu, ... Journal of cancer research and clinical oncology 138, 1155-1163, 2012 | 35 | 2012 |
| Novel ferrocenyl pyrazoles inhibit breast cancer cell viability via induction of apoptosis and inhibition of PI3K/Akt and ERK1/2 signaling H Atmaca, AN Özkan, M Zora Chemico-Biological Interactions 263, 28-35, 2017 | 32 | 2017 |
| Anti-angiogenic effects of trabectedin (Yondelis; ET-743) on human breast cancer cells H Atmaca, S Uzunoglu European Cytokine Network 25, 1-7, 2014 | 32 | 2014 |
